Drug
Probiotic Formula Capsule
Probiotic Formula Capsule is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_2
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
withdrawn125%
completed250%
not_yet_recruiting125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan
NCT04223479
not_yet_recruitingnot_applicable
A Study on Probiotic Formula in Autistic Children
NCT06419530
withdrawnphase_2
Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients
NCT03742596
completedphase_4
Multi-strain Probiotic in the Management of IBS-D
NCT03251625
Clinical Trials (4)
Showing 4 of 4 trials
NCT04223479Phase 2
Effect of Probiotic Supplementation on the Immune System in Patients With Ulcerative Colitis in Amman, Jordan
NCT06419530Not Applicable
A Study on Probiotic Formula in Autistic Children
NCT03742596Phase 2
Effect of Probiotics Supplementation on the Side Effects of Radiation Therapy Among Colorectal Cancer Patients
NCT03251625Phase 4
Multi-strain Probiotic in the Management of IBS-D
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4